Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0U1XQ
|
|||
| Drug Name |
ORGN001
|
|||
| Indication | Molybdenum cofactor deficiency [ICD-11: 5B5K.A; ICD-10: E00-E90] | Phase 2/3 | [1] | |
| Company |
Origin Biosciences
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT02629393) Study of ORGN001 (Formerly ALXN1101) in Neonates, Infants and Children With Molybdenum Cofactor Deficiency (MOCD) Type A. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.